Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
AstraZeneca
Express Scripts
Covington
Cerilliant
Argus Health
Cantor Fitzgerald
Fuji

Generated: January 24, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine

« Back to Dashboard

insulin glargine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eli Lilly And Co BASAGLAR insulin glargine SOLUTION;SUBCUTANEOUS 205692 NDA Eli Lilly and Company 0002-7715-59 5 SYRINGE in 1 CARTON (0002-7715-59) > 3 mL in 1 SYRINGE (0002-7715-01)
Eli Lilly And Co BASAGLAR insulin glargine SOLUTION;SUBCUTANEOUS 205692 NDA Eli Lilly and Company 0002-7715-63 1 SYRINGE in 1 CARTON (0002-7715-63) > 3 mL in 1 SYRINGE
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Fish and Richardson
Fuji
Healthtrust
Queensland Health
US Department of Justice
Julphar
Chubb